Mike Rawling

Director - Medicinal Chemistry @Transition Bio, Inc.

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2026 — Present

Director - Medicinal Chemistry @Transition Bio, Inc.

View department →

Cambridge, GB

EDUCATION

2005 — 2009

The University of Sheffield

MChem Chemistry (First Class)

2009 — 2011

Cardiff University / Prifysgol Caerdydd

Doctor of Philosophy (PhD), Organic Chemistry

2011 — 2013

University of Strathclyde

Doctor of Philosophy (PhD), Organic Chemistry

ABOUT MIKE RAWLING

A results-driven Lead Medicinal Chemist with over a decade of biotech experience post-PhD. Specialises in driving AI-enabled small molecule drug discovery programmes from hit ID to pre-clinical candidate nomination within accelerated timelines across diverse therapeutic areas including oncology, neurology, and infectious diseases.Key achievements: Major contributions to three development candidates (two for CNS indications), four new programme portfolio entries, successful drug repurposing (FDA-approved), and securing a large pharma collaboration worth up to $594m. Lead author of BenevolentAI\'s first clinical candidate disclosure paper (https://doi.org/10.1021/acs.jmedchem.5c00279).

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mike Rawling — Director - Medicinal Chemistry at Transition Bio, Inc. in Cambridge, GB | Unifers